The disease is characterized by 10% or more clonal plasma cells in the bone marrow (BM) and the production of a monoclonal immunoglobulin (M-protein), accompanied by one or more myeloma-defining events [1]. The gene discussed is MYOM2; the disease is plasma cell myeloma.